Ellomay Capital Ltd Ordinary Sh (DE:NUR)
FRANKFURT:NUR
Holding DE:NUR?
Track your performance easily

Ellomay (NUR) Dividend Date & History

0 Followers
Ellomay (DE:NUR) has no upcoming dividends

Dividend Amount Per Share​

NUR Dividend Yield Range

Currently, no data available
Please return soon. This page is being updated.

NUR Dividend History

Ex-Date
Record Date
Payment Date
Frequency
Declaration Date
Amount
Apr 06, 2016Apr 06, 2016Apr 20, 2016Not Available€0.20
Apr 04, 2016Apr 06, 2016Apr 20, 2016Not AvailableMar 26, 2016€0.20
The table shows Ellomay Capital Ltd Ordinary Sh’s dividend history, including amount per share, payout frequency, declaration, record, and payment dates.

FAQ

Does Ellomay Capital Ltd Ordinary Sh pay dividends?
Yes, DE:NUR has paid a dividend within the past 12 months.
    How much is Ellomay Capital Ltd Ordinary Sh's dividend?
    Ellomay Capital Ltd Ordinary Sh (DE:NUR) does not pay a dividend
    When is Ellomay Capital Ltd Ordinary Sh ex-dividend date?
    Ellomay's previous ex-dividend date was on Apr 06, 2016. Ellomay shareholders who own DE:NUR stock before this date received Ellomay's last dividend payment of €0.2 per share on Apr 20, 2016. DE:NUR's next ex-dividend date has not been announced yet.
      When is Ellomay Capital Ltd Ordinary Sh dividend payment date?
      Ellomay’s next quarterly payment date is on Apr 20, 2016, when Ellomay shareholders who owned DE:NUR shares before Apr 06, 2016 received a dividend payment of €0.2 per share. Add DE:NUR to your watchlist to be reminded of DE:NUR's next dividend payment.
        Does Ellomay Capital Ltd Ordinary Sh have sufficient earnings to cover their dividend?
        Ellomay Capital Ltd Ordinary Sh (DE:NUR) does not pay a dividend.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis